ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
about
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.Biological function and histone recognition of family IV bromodomain-containing proteins.ATAD2 in cancer: a pharmacologically challenging but tractable target.The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes.
P2860
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
@en
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
@nl
type
label
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
@en
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
@nl
prefLabel
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
@en
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
@nl
P2093
P2860
P356
P1433
P1476
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
@en
P2093
Christopher J Ott
James E Bradner
Mátyás Gorjánácz
Oliver von Ahsen
Sarah Vittori
Seong Joo Koo
Simon J Holton
Volker Badock
P2860
P304
70323-70335
P356
10.18632/ONCOTARGET.11855
P407
P577
2016-09-06T00:00:00Z